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ABSTRACT 
Diabetes mellitus is one of the risk factors in the development of vascular complications. Decreased nitric oxide 
(NO) production and increased lipid peroxidation in diabetes mellitus are the dominant exaggerating factors. 
Mormodica charantia (MC) was proven to be useful in improving diabetes mellitus and its complications. In the 
present study, a total of 40 male Sprague-Dawley rats were used. Diabetes was induced by a single dose 
(50 mg/kg) of streptozotocin (STZ), intramuscularly. Following 4 weeks of STZ induction, the animals were 
equally divided into five groups (n = 8); Control group (Ctrl), control group treated with MC (Ctrl-MC), diabetic 
untreated group (DM-Ctrl), diabetic group treated with MC (DM-MC) and diabetic group treated with metformin 
150 g/kg (DM-Met). Oral administration of the MC fruit extract (1.5 g/kg) was continued for 28 days. DM-MC 
group showed a significant decrease (P < 0.05) in blood pressure, total cholesterol and triglyceride levels com-
pared to the DM-Ctrl group. Aortic tissue NO level was significantly increased and malondialdehyde level was 
decreased in the DM-MC group. Immunohistochemical staining showed an increase in eNOS expression in the 
endothelial lining of the DM-MC group. Similarly, morphological deterioration of the aortic tissues was reverted 
to normal. In summary, treatment with the MC fruit extract exerted the significant vasculoprotective effect in the 
type 1 diabetic rat model.  
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INTRODUCTION 
Diabetes Mellitus (DM) is a chronic oxi-
dative stress disorder which occurs due to 
the insulin deficiency or resistance. Chronic 
hyperglycaemia causes glycation of the ad-
vanced glycoproteins and leads to the devel-
opment of macro and microvascular compli-
cations (Virdi et al., 2003). Increase free rad-
ical formation in the diabetic state promotes 
the increase in oxidative stress and decrease 
in anti-oxidant level (Sathishsekar and 
Subramaniam, 2005). This mechanism en-
hances the lipotoxicity and endothelial dys-
function in certain tissues (Lin et al., 2011; 
Stratton et al., 2000). Hyperglycaemia in-
duces a large number of alterations in the 
vascular tissue that accelerate the vascular 
wall lesions. Exposure of endothelial cells 
with higher glucose levels leads to a reduc-
tion in the nitric oxide (NO) level, a potent 
endothelium-derived vasodilator in the major 
blood vessels. The production of NO de-
pends on the endothelial nitric oxide syn-
thase (eNOS) enzyme which is involved in 
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the regulation of vascular tone (Giugliano et 
al., 1996). Therefore, increased oxidative 
stress is responsible for the development of 
macrovascular complications in DM. 
A wide array of dietary food was report-
ed to control oxidative stress and lipotoxicity 
in DM. Momordica charantia (MC), belongs 
to the family of Cucurbitaceae. This dietary 
food has been widely used in South East 
Asia. It is known as bitter gourd or bitter 
melon in English and ‘Peria’ in local Malay-
sia (Grover and Yadav, 2004). The fruit of 
MC is enriched with steroidal saponins 
known as charantins, insulin-like peptides 
and alkaloids. It contains several amino ac-
ids, which reduce the blood glucose level 
thereby preventing DM. Previous studies re-
ported MC to possess hypoglycaemic, anti-
hyperglycaemic (Raman and Lau 1996), hy-
potensive (Ojewole et al., 2006) and lipid 
lowering properties (Ali et al., 1993). A re-
cent pharmacological study with aqueous ex-
tract of MC showed a significant reduction in 
the blood glucose level compared to chloro-
form extract (Karunanayake et al., 1990). 
The fruit extract of MC was tested in var-
ious tissues of diabetic animal model and the 
active compounds from the extract were dis-
cussed in past studies (Lii et al., 2009; Pyc-
nogenolu and Dysfunkciu, 2013). However, 
the effect of the MC fruit extract on the vas-
cular tissues in DM is still remained obscure. 
Hence, the present study was designed to ob-
serve the protective effect of the MC fruit ex-
tract on vascular complications in type 1 
DM. Such investigations will open the door 
for the potential therapeutic approaches of 
the MC fruit extract for future studies. 
 
MATERIALS AND METHODS 
Preparation of MC fruit aqueous extract 
The MC fruits (7 kg) were purchased 
from the local market, Selayang, Malaysia. 
The entire plant was identified by a Botanist 
from Universiti Kebangsaan Malaysia 
(UKMB 40067). The sun-dried fruits of MC 
were cut into small pieces, powdered and ex-
tracted with distilled water between 75-80 °C 
for 3 hours. The extracts were evaporated 
at -80 °C freezer and stored at 4 °C until use. 
In this study, the oral dosage of 1.5 g/kg 
body weight was used for the treatment of 
animals (Waheed et al., 2008). 
 
Animals 
We used forty (n = 40), male Sprague-
Dawley rats weighing 250 - 350 g obtained 
from Laboratory Animal Resource Unit, 
Faculty of Medicine, UKM, Malaysia. Prior 
ethical approval was taken before starting the 
experiment. All efforts were made to mini-
mize animal suffering and to reduce the 
number of animals used. The rats were ac-
climatized for 1 week. During the experi-
ment, the rats were kept in an individual 
plastic cage, maintained under standard envi-
ronmental conditions, temperature at 25-
28 °C (12-h light/dark cycle) with free ac-
cess to tap water and rat pellets.  
 
Induction of diabetes 
Following overnight fasting, the experi-
mental group of rats received a single intra-
muscular injection of a dose of 50 mg/kg 
body weight of streptozotocin (STZ) (Len-
zen, 2008) whereas control groups received 
0.9 % normal saline. Three days following 
STZ induction, the fasting blood glucose 
level was measured in all the rats. A fasting 
blood glucose level of more than 8 mmol/L 
was considered as diabetic (Thent et al., 
2012). Following 4 weeks of STZ induction, 
the animals were equally divided (n = 8) into 
the control group (Ctrl) and the control 
group treated with MC extract (Ctrl-MC), di-
abetic control group (DM-Ctrl), the diabetic 
group treated with MC extract (DM-MC) and 
the diabetic group treated with 150 mg/kg 
metformin (DM-Met). The dose of metfor-
min was adopted from a previous study 
(Scheen, 2013). The treatment was continued 
for 28 days.  
 
Measurement of blood pressure 
Blood pressure was monitored by non-
invasive tail-cuff CODA system. The rats 
were exposed under the sunlight for 10 
minutes before the measurement of the blood 
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pressure. The systolic, diastolic and mean ar-
terial blood pressures were measured at base-
line, pre-treatment and post-treatment fol-
lowing MC administration. An average was 
taken following 5 readings at each measure-
ment (Fokkema et al., 1995). 
 
Measurement of fasting serum lipid levels 
(FSL) 
Total cholesterol, HDL cholesterol, LDL 
cholesterol and Triglycerides were measured 
in plasma of individual rats from each group 
at baseline, pre-treatment and post-treatment 
periods. The blood was collected from a ret-
ro-orbital vein. The collected whole blood 
was then sent to Pathlab & Clinical laborato-
ry (M) Sdn Bhd Malaysia for further analy-
sis. 
 
Collection of tissues 
At the end of the study, i.e. at 28 days 
following MC treatment, the rats were sacri-
ficed with the overdose of diethyl ether. The 
thoracic part of aortic tissues were excised, 
cleaned and the adhered connective tissues 
were removed. Lipid peroxidation and nitric 
oxide level were measured by homogenizing 
the thoracic aorta. For microscopic study, the 
aortic tissue was incised into 2 mm3 diame-
ters and then fixed with 10 % formalin. 
 
Determination of malondialdehyde level 
Malondialdehyde (MDA) level was esti-
mated by the double heating method (Draper 
and Hadley, 1989). The principle of the 
method is the spectrophotometric measure-
ment of the colour generated by the reaction 
of thiobarbituric acid (TBA) with MDA. For 
this purpose, 2.5 ml of the I-1trichloroacetic 
acid solution was added to 0.5 ml superna-
tant in each centrifuge tube and the tubes 
were placed in hot water bath for 15 minutes. 
Then, the tubes were centrifuged again and 
the supernatant was added to the TBA solu-
tion in a test tube. The concentration of 
MDA was calculated by the absorbance co-
efficient of the MDA-TBA complex and was 
expressed as nanomoles per gram of protein. 
 
Determination of nitric oxide level 
Aortic tissue samples were homogenized 
and centrifuged. Then, Premix was prepared 
by mixing 50 µL 1.0 nM standard and 
450 µL distilled water. A 100 µL of each 
homogenised sample was added to the sepa-
rate wells. Then, Working Reagent (WR) 
was prepared and mixed in each sample and 
standard tube and was incubated for 10 
minutes at 60 °C. Briefly, it was then centri-
fuged and transferred into the wells. Absorb-
ance was read at 500 – 570 nm (peak 540 nm) 
(Guo et al., 2000). 
 
Immunohistochemical analysis 
After perfusion and paraffin embedding, 
the slides were deparaffinized and rehydrated 
in Xylene series. The slides were rinsed until 
ready for staining. The primary antibody was 
incubated and following 24 hours of incuba-
tion, the secondary antibody was added. 
Slides were tested using PBS as negative 
control. The eNOS expressions were ob-
served by the double blinded fashion. (Co-
sentino and Luscher, 1999). 
 
Light microscopy 
The thoracic part of aortic tissues were 
processed for fixation, dehydration, clearing, 
infiltration, impregnation and embedding. 
The tissues from individual rats were fixed 
with 10 % formalin. The tissues were dehy-
drated with alcohol series and cleaned with 
xylene in automatic tissue processor unit. 
The tissues were paraffinized and the blocks 
were cut by using the microtome (5 μm 
thickness). Eventually, thickness of the tuni-
ca intima (TI) and tunica media (TM) were 
measured in each group under image Ana-
lyzer software (Moraes-Teixera et al., 2010). 
The sections were then, stained with haemo-
toxylin and eosin; alcian blue and orcinol 
stainings. 
 
Statistical analysis 
The data were presented as the mean ± 
standard error of mean (SEM). Statistical 
analysis was carried out by using ANOVA 
followed by Bonferroni and/or Tukey’s post-
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hoc test. The value of P < 0.05 was consid-
ered to be significant. All statistical analysis 
was performed using the SPSS statistical 
package version 21.0 (SPSS Inc., Chicago, 
USA). 
 
RESULTS 
Blood pressure 
The baseline, pre-treatment and post-
treatment SBP, DBP and MBP were meas-
ured in each rat. At the end of pre-treatment, 
a significant increase (P < 0.05) in SBP, 
DBP and MBP were observed in all the ex-
perimental diabetic groups. Following 4 
weeks of treatment (i.e. post-treatment peri-
od), there was a significant decrease 
(P < 0.05) in SBP, DBP and MBP in the 
DM-MC group, i.e. 122.5 ± 8.8 mmHg, 
80.17 ± 10.21 mmHg and 101.33 ± 9.5 
mmHg, respectively, compared to the DM-
Ctrl group, I. e. 147.67 ± 8.98 mmHg, 98.33 
± 6.86 mmHg and 123 ± 7.92 mmHg, re-
spectively. These findings were compatible 
with the findings in DM-Met group. No sig-
nificant changes were observed between the 
non-diabetic groups (Figure 1). 
 
Fasting serum lipid level 
At the end of the pre-treatment period, 
there was an increase in the fasting serum li-
pid level in all the experimental diabetic 
groups. Following 4 weeks of treatment, 
there was a significant decrease (P < 0.05) 
TC and TG levels in the DM-MC group 
(1.42 ± 0.08 mmol/L and 0.57 ± 0.08 mmol/L, 
respectively) compared to the DM-Ctrl 
group (2.18 ± 0.19 mmol/L and 0.95 ± 
0.09 mmol/L, respectively). Similar findings 
were observed in DM-Met group. However, 
no changes were observed with regard to the 
levels of HDL and LDL in all the groups in 
the post treatment period (Figure 2). 
 
Aortic tissue MDA level 
At the end of the study, aortic tissues 
were homogenized to analyse the MDA lev-
el. DM-MC group showed a significant de-
crease (P < 0.05) in the MDA level (6.06 ± 
0.86 nmol/mg) compared to the DM-Ctrl 
group (19.73 ± 1.57 nmol/mg). Furthermore, 
DM-Met group (9.13 ± 1.87 nmol/mg) 
showed slightly decreased (P < 0.05) MDA 
level. However, the Ctrl-MC group showed 
no significant changes in MDA level com-
pared to the Ctrl group (Table 1). 
 
 
 
Figure 1: Effect of MC fruit extract on the 
blood pressure of Sprague-Dawley rats  
* Indicates a significant decrease (P < 0.05) 
in a(SBP), b(DBP) and c(MBP) mmHg of 
the DM-MC group compared to the DM-Ctrl 
group. 
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Figure 2: Effect of MC fruit extract on the fasting serum lipid profile of Sprague-Dawley rats.  
*Indicates a significant decrease (P<0.05) in a(TC) and b(TG) levels of the DM-MC group compared to 
the DM-Ctrl group. # Indicates no significant difference (P>0.05) in c(LDL) and d(HDL) levels. 
 
 
Table 1: Effect of MC fruit extract on MDA and 
Nitric Oxide levels in the aortic tissues 
Groups 
Malondialdehyde 
(MDA) level 
(nmol/mg) 
Nitric Oxide (NO) 
level 
(µM)
Ctrl 11.12 ± 1.29 956.25 ± 99.56 
Ctrl-MC 9.44 ± 1.33 1137.65 ± 142.14 
DM-Ctrl 19.73 ± 1.57 785.83 ± 99.53 
DM-MC 6.06 ± 0.86* 1329.58 ± 104.61*
DM-Met 9.13 ± 1.87 1196.25 ± 64.68 
Values were expressed at mean ± SEM. * Indicates signifi-
cant changes (P<0.05) observed in the aortic tissues MDA 
and NO levels in the DM-MC group compared to the DM - 
Ctrl group.  
 
Aortic tissue Nitric Oxide level 
Nitric oxide (NO) level was analysed in 
the aortic tissues of individual rats. DM-MC 
group showed a significant increase 
(P < 0.05) in the NO level (1329.58 ± 
104.61 µM) compared to the DM-Ctrl group 
(785.83 ± 99.53 µM). The result was found 
to be correspondence with DM-Met group 
(1196.25 ± 64.68 µM). However, Ctrl-MC 
group showed no significant increase in NO 
level compared to the Ctrl group (Table 1). 
 
eNOS expression in aortic tissue 
Under immunohistochemical staining, 
endothelial nitric oxide synthase (eNOS) ex-
pression was shown as black in colour in the 
endothelial lining of the tunica intima. Find-
ings showed little or no eNOS expression in 
the DM-Ctrl group. The thickness of TM al-
so prominently increased. There was reduced 
elasticity of the elastic fibres in the DM-Ctrl 
group. However, the aortic tissue in the DM-
MC group showed an increase in the eNOS 
expression, less TM thickness and more elas-
ticity compared to the DM-Ctrl group. Fur-
thermore, DM-Met group showed increased 
expression of eNOS in the endothelial lining. 
No changes in eNOS expression were ob-
served in the non-diabetic groups (Figure 3). 
 
Histomorphometric analysis of thickness of 
TI and TM 
The histomorphometric analysis of the 
thickness tunica intima (TI) and tunica media 
(TM) were observed by using the image An-
alyzer software. Four measurements per im-
age were obtained at 0°, 90°, 180° and 270° 
and the mean was taken (Table 2). It was ob-
served that there were no significant differ-
ences in the thickness of TI in all groups of 
rats. However, the thickness of TM was 
found to be significantly decreased in the 
DM-MC group (89.31 ± 1.65 µm) compared 
to the DM-Ctrl group (121.72 ± 2.95 µm). 
Similar findings were observed in the DM-
Met group. 
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Figure 3: Photomicrograph showing cross sections of the thoracic aorta under immunohistochemical 
staining for eNOS expression. a(Ctrl), b(Ctrl-MC), c(DM-Ctrl), d(DM-MC), e(DM-Met). Note the in-
crease eNOS expression in endothelial lining (stained black, blue arrows) in c(DM-Ctrl). LM X 200 
 
 
 
Histological findings 
Loss of endothelial cells in TI, disrupted 
elastic lamellae and increased thickness were 
observed in the DM-Ctrl group. However, 
DM-MC group showed less pathological 
changes compared to the DM-Ctrl group. 
The presence of endothelial cells in TI and 
reduced TM thickness was observed in the 
DM-MC group under H&E staining. Similar 
features were observed in the DM-Met group 
(Figure 4). Alcian blue staining is a special 
staining used to stain the connective tissue 
deposition, especially acid mucopolysaccha-
rides. The increased acid mucopolysaccha-
rides deposition was observed in the DM-
Ctrl group which appeared blue in colour. 
However, less acid mucopolysaccharides 
deposition with blue staining in the DM-MC 
group was observed compared to the DM-
Ctrl group (Figure 5). Orcinol staining is 
used to delineate the deposition of elastic fi-
bres in the large arteries. The histological 
findings of thoracic aorta in the DM-Ctrl 
group showed decrease in tortuosity of the 
elastic fibres. However, these degenerative 
changes were found to be improved in the 
DM-MC group. Tortuous elastic fibres with 
intact endothelial cells was observed in the 
DM-MC group. Similar findings were ob-
served in the DM-Met group (Figure 6). 
 
Table 2: Effect of MC fruit extract on thickness of 
Tunica Intima (TI) and Tunica Media (TM) in the 
aortic tissues 
Groups Thickness TI (µm) 
Thickness TM 
(µm) 
Ctrl 1.61 ± 0.11 85.62 ± 1.41 
Ctrl-MC 1.73 ± 0.10 86.07 ± 1.78 
DM-Ctrl 1.81 ± 0.04 121.72 ± 2.95 
DM-MC 1.79 ± 0.11 89.31 ± 1.65* 
DM-Met 1.75 ± 0.16 86.82 ± 1.75 
Values were expressed at mean ± SEM. There were no sig-
nificant changes in TI thickness between all groups of rats.  
*Indicates significant changes (P<0.05) observed in TM thick-
ness in the DM-MC group compared to the DM - Ctrl group 
 
 
Figure 4: Photomicrograph showing transverse 
sections of the thoracic aorta under H&E stain-
ing. a(Ctrl), b(Ctrl-MC), c(DM-Ctrl), d(DM-MC), 
e(DM-Met). Note the relative thickness of the TM 
in c(DM-Ctrl) with double headed arrow. TM= 
Tunica Media, L= Lumen. LM X 200 
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Figure 5: Photomicrograph showing transverse 
sections of the thoracic aorta under Alcian blue 
staining. a(Ctrl), b(Ctrl-MC), c(DM-Ctrl), d(DM-
MC), e(DM-Met). Note the presence of acid mu-
copolysaccharides (stained blue, yellow arrows) 
in c(DM-Ctrl). TM= Tunica Media, LM X 200 
 
 
Figure 6: Photomicrograph showing transverse 
sections of the thoracic aorta under Orcinol stain-
ing. a(Ctrl), b(Ctrl-MC), c(DM-Ctrl), d(DM-MC), 
e(DM-Met). Note the reduced tortuosity of elastic 
fibres in c(DM-Ctrl).  
TM= Tunica Media, EC= Endothelial cell, L= Lu-
men. LM X 200 
 
 
DISCUSSION 
In the present study, a significant in-
crease (P < 0.05) in SBP, DBP and MBP in 
the DM-Ctrl group was observed following 
post-treatment period. It was reported that 
STZ-induced DM rats have a high risk of in-
crease in the blood pressure (Browne et al., 
2003). SBP plays a crucial role in DM, by 
increasing the pumping effect of the left ven-
tricle. It was stated that the increase in colla-
gen deposition and myocardial fibrosis leads 
to develop the systolic hypertension (Boudi-
na and Abel, 2007). In an another study, it 
was mentioned that chronic hyperglycaemia 
without any treatment leads to increase DBP 
(Ojewole et al., 2006). Therefore, an increase 
in both SBP and DBP, leads to an increase in 
MBP which was observed in the experi-
mental diabetic rats. The blood pressure in 
the DM-MC group was found to be signifi-
cantly decreased compared to the DM-Ctrl 
group (Figure 1). The exact hypotensive 
mechanisms of the MC extract for lowering 
blood pressure, still remains unclear. It can 
be explained that the active compound, lep-
tin, present in the MC fruit extract attenuates 
the blood pressure. Leptin proved to reduce 
the blood pressure by increasing the anti-
oxidant and nitric oxide efficiency (Sharma 
et al., 1996). No significant difference in the 
blood pressure was noted in the Ctrl-MC 
group.  
Besides the blood pressure, the fasting 
serum lipid (FSL) profile of the individual 
rats was also examined in the present study. 
Research reports mentioned the diabetic pa-
tients to have a high risk of developing dys-
lipidaemia (Al-Neaimy, 2008). Non-enzyma-
tic reaction between the lipoproteins and hy-
perglycaemia leads to the overproduction of 
advanced glycosylation end products (AG-
Es), which accelerates the hyperlipidaemia in 
a diabetic state (Aronson and Rayfield, 
2002). In the present study, it was noted that 
there was a significant increase (P < 0.05) in 
total cholesterol (TC) and triglyceride (TG) 
in all the diabetic rats compared to the con-
trol rats during the pre-treatment period. 
Traditionally, normal mice and rats have not 
been ideal models for cardiovascular re-
search since the animals have very low levels 
of LDL and high levels of HDL (Gajda et al., 
2007). Therefore, no significant changes in 
LDL and HDL were observed in all the 
groups of rats, throughout the study. Follow-
ing 28 days of treatment, DM-MC group 
showed a significant decrease (P < 0.05) in 
TC and TG level compared to the DM-Ctrl 
group (Figure 2). The findings agreed with 
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the previous study which reported a decrease 
in TC and TG levels in Wistar rats following 
treatment with the MC fruit extract (Fer-
nandes et al., 2007). It was documented in 
the early studies that MC fruit extract breaks 
down the hepatic enzymes involved in gluco-
se and lipid metabolism, to reduce the serum 
lipid level (Wohaieb and Godin, 1987; Bai-
ley and Day, 1989). However, purified active 
fractions of the MC fruit extract are yet to be 
tested for its hypolipidaemic effects.  
Increased lipid peroxidation plays a key 
role in the pathogenesis of vascular compli-
cation in the diabetic state (Ogura et al., 
2006). The increased MDA level is associat-
ed with an increase in the free radical pro-
duction in the diabetic state. Several studies 
were conducted on peroxidative stress-indu-
ced atherosclerosis (Prasad, 2005). In the 
present study, increased aortic tissue MDA 
level was found in the DM-Ctrl group. In 
DM-MC group, a significant decrease 
(P < 0.05) in the aortic tissues MDA level 
was observed compared to the DM-Ctrl 
group (Table 1). Earlier study showed the ef-
fect of MC fruit extract on the plasma MDA 
level in alloxan-induced diabetic rats (Tripa-
thi and Chandra 2009). In the presence of an-
ti-oxidant compounds (e.g. plant phenols), 
MC fruit extract protects membrane lipid pe-
roxidation (Bhoomi et al., 2013). 
Nitric oxide (NO), a potent vasodilator, 
inhibits leukocyte adhesion, smooth muscle 
proliferation and plaque instability due to the 
presence of anti-thrombotic property (De 
Dios et al., 2007). In the present study, the 
DM-Ctrl group showed significantly reduced 
(P < 0.05) NO level. It was postulated that, 
reduced bioavailability of L-arginine, the 
precursor of NO, is an important factor con-
tributing to the development of vascular 
complication in type 1 DM rats (Crea et al., 
1997). DM-MC group showed increased NO 
level compared to the DM-Ctrl group (Table 
1). This may be due to the presence of the 
charantin compound in the MC fruit extract 
which produces lipopolysaccharide (LPS)-
induced NO (Lii et al., 2009).  
The enzyme nitric oxide synthase 
(eNOS), regulates the endothelial function in 
the vascular wall. In type 1 DM, the deficient 
insulin decreased the vascular relaxation 
through eNOS activity in the endothelial 
cells (Yan et al., 2006; Quintela et al., 2012). 
In the present study, the DM-Ctrl group 
showed less eNOS expression in the endo-
thelial lining of the tunica TI under immuno-
histochemical staining. However, increased 
eNOS expression was observed in the tho-
racic aorta of the DM-MC group (Figure 3). 
It is believed that the anti-oxidant effect of 
MC phenolic and flavonoid compounds play 
a major role in the vasculoprotective mecha-
nism in the diabetic state. Besides anti-
oxidant and glycemic control, MC plays an 
important role in the protection of vascular 
endothelium against oxidative stress induced 
by ROS and nitrogen species (Pycnogenolu 
and Dysfunkciu, 2013).  
In the present study, the morphological 
changes in thoracic aorta were analysed un-
der the light microscope. The thickness of TI 
and TM of the thoracic aorta were measured 
(Table 2). It was found out that, following 8 
weeks of STZ induction, the DM-Ctrl group 
showed increase in the TM thickness (Figure 
4). A previous study explained that the in-
crease in the thickness of TM was due to the 
increased proliferation of smooth muscle 
cells in DM (Rosenfield and Ross, 1990). 
Under Alcian blue staining, more acid mu-
copolysaccharide deposition was shown in 
the aortic tissue of the DM-Ctrl group (Fig-
ure 5). An earlier clinical study showed that 
abnormal carbohydrate-protein substances in 
DM leads to the formation of acid mucoply-
saccharides in the large blood vessel (Budin 
et al., 2009). Moreover, it was reported that 
elastin and collagen content are altered in the 
arterial wall of DM patients as well as in the 
experimentally-induced diabetic animals. 
Orcinol staining was used to identify the fea-
tures of the elastic fibres. In the DM-Ctrl 
group, there was less deposition of elastic fi-
bres with reduced tortuosity in the vascular 
wall (Figure 6). In the DM-MC group, less 
abnormality was observed when viewed un-
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der the light microscope. The thickness of 
TM was found to be reduced significantly 
(Table 2). It was believed that MC has a po-
tent effect in improving the development of 
vascular wall damage. It can be explained 
that the alteration in glycogen metabolism 
following administration with the MC fruit 
extract reduced the proteoglycans by reduc-
ing the sugar contents (Jayasooriya et al., 
2000). Therefore, DM-MC group showed 
less acid mucopolysaccharide depositions in 
the aortic tissue under Alcian blue staining 
compared to the DM-Ctrl group. The in-
creased tortuosity of elastic fibres compared 
to the DM-Ctrl group under Orcinol staining 
might be due to the presence of anti-
atherogenic and anti-lipidaemic properties in 
the MC fruit extract (Komolafe et al., 2013). 
In the present study, DM-Met group was 
used as a positive control group as metfor-
min is known as the standard oral hypogly-
caemic agent for the treatment of diabetes 
mellitus. The results achieved from DM-MC 
group was compared to the DM-Met group. 
Interestingly, the present findings were in 
accordance with the DM-Met group. With 
regard to the aortic tissue MDA level, DM-
Met group did not show any significant posi-
tive effect. It may be due to the deficient an-
tioxidant compounds present in the synthetic 
agent like metformin.  
From the present findings, it was ob-
served that the administration with MC fruit 
extract for 28 days improved the vascular 
complication by decreasing the blood pres-
sure, serum total cholesterol, triglyceride 
levels, aortic tissue MDA level and increas-
ing aortic tissue NO level in type 1 diabetic 
rat model. These results were confirmed by 
the tissue histomorphometery, immunohisto-
chemistry (eNOS expression) and histologi-
cal analysis. In addition, the results of the 
MC fruit extract were in accordance with an 
oral hypoglycaemic agent, metformin. Our 
results are a key to establish the scientific 
foundation of MC fruit in improving the dia-
betic vascular complication. Further investi-
gations in determining the mechanism of ac-
tion of the MC fruit extract in the treatment 
of vascular complications arising due to dia-
betes mellitus are required.  
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